Penza, 13 November 2014. PenzaNews. The Penza-based “Biosintez” and LLC “Protek-SVM” have settled the debt issue out of court, the press service of JSC “Biosintez” told PenzaNews agency.

© PenzaNewsBuy the photo

“The decision was based on long-standing and successful cooperation between the companies,” the press service noted.

The management staff of LLC “Protek-SVM” stressed the importance of continued cooperation with “Biosintez” and affirmed there will be no interruptions in shipments to production.

In his turn, Dmitry Boldov, General Director of JSC “Biosintez” since October 28,2014, stated his company and LLC “Protek-SVM” remain in good partnership, and assured his business will do anything necessary to expand their cooperation.

Currently, it involves buying high-quality medical substances from “Protek-SVM” and feedback production transfers from “Biosintez” for retail sales.

JSC “Biosintez” is one of the leading Russian full-circle production pharmaceutical enterprises. Its production ranges from medical substances to retail-ready medicine in various forms of application.

LLC “Protek-SVM” is one of the largest pharmaceutical substances supplier that provides the necessary materials for producing many high-end modern medicinal products.